Cover Image

Adverse drug events with iron chelation drugs in thalassemic patients attending a day care thalassemia centre in Tertiary Care Govt. Medical College in North India

Saved in:

Bibliographic Details
Main Authors:	Kishore Kumar Digra (Author), Sanjeev Kumar Digra (Author), Rajesh Kaul (Author), Subhash Singh Slathia (Author)
Format:	Book
Published:	Elsevier, 2016-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Estimating the prevalence of vitamin B12 and vitamin D deficiency in children with thalassemia major
by: Abhishek Chambial, et al.
Published: (2024)

Myocardial iron is strongly associated with reproductive function in beta-thalassemic women under chelation therapy
by: M. A. Castaldi, et al.
Published: (2020)

Side effect of deferiprone as iron chelator in patient with thalassemia
by: Mikhael Yosia, et al.
Published: (2018)

To determine the prevelence of hypoparathyroidism in children with thalassemia major and its corelation to serum ferritin
by: Rajnesh Kumar, et al.
Published: (2022)

Barriers to adherence to iron chelation therapy among adolescent with transfusion dependent thalassemia
by: Rafaa Mohamed, et al.
Published: (2022)

Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy
by: Parinaz Zarghamian, et al.
Published: (2020)

Awareness of the Thalassemic Patients' Parents toward Thalassemia in Kirkuk City
by: Yousif Abdulmuhsin Salih
Published: (2014)

Effect of COVID-19 infection on the clinical course and the outcome of paediatric patients with leukaemia
by: Rajneesh Kumar, et al.
Published: (2022)

Comparison of cardiac dysfunction in thalassemia major patients using deferoxamine or deferiprone as an iron-chelating agent
by: Rosalina Josep, et al.
Published: (2012)

Synthesis of Deferiprone as a Widely Used Iron-Chelating Drug for the Treatment of Iron-Overload Diseases
by: Sara Sadeghian, et al.
Published: (2024)

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes
by: Taher AT, et al.
Published: (2016)

Dual oral iron chelation in children with transfusion dependent beta thalassemia real world efficacy data
by: Amitoj Singh Chadha, et al.
Published: (2022)

Psychosocial Problems of Thalassemic in A Tertiary Care Centre, Indore
by: Sameer Inamdar, et al.
Published: (2016)

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes
by: Kontoghiorghe CN, et al.
Published: (2016)

Palpable Abdominal Masses in Indian Females: A Prospective Analysis
by: Ravinder Kumar, et al.
Published: (2023)

Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior
by: Shahla Ansari, et al.
Published: (2017)

United we stand - a five year study on the use of combination chelation for iron overload in children with thalassemia major
by: J. Dhaarani, et al.
Published: (2017)

Obstetric Outcome of Pregnancy with Fibroids: An Observational Study
by: Madhu Digra
Published: (2024)

To determine the prevalence and patterns of side effects of chemotherapy in children with acute lymphoblastic leukemia
by: Sunali Jamwal, et al.
Published: (2024)

A case report on a patient with acute lymphoblastic leukaemia, with unusual side effects, using the intravenous route for administration of cytarabine versus the subcutaneous route
by: Aadarshita Verma, et al.
Published: (2024)

Lipid Peroxidation and Antioxidant Status in Î²-Thalassemic Patients: Effect of Iron Overload
by: Bassm N. Aziz, et al.
Published: (2017)

Lipid Peroxidation and Antioxidant Status in Î²-Thalassemic Patients: Effect of Iron Overload
by: Bassm N. Aziz, et al.
Published: (2017)

Effectiveness of emicizumab in preventing bleeding events in hemophilia A patients: An observational study
by: Nikhil Gupta, et al.
Published: (2024)

Urinary hepcidin levels in children with beta-thalassemia major on chelation therapy
by: Kritika Goel, et al.
Published: (2022)

Potential Treatment of Retinal Diseases with Iron Chelators
by: Wanting Shu, et al.
Published: (2018)

The Utility of Iron Chelators in the Management of Inflammatory Disorders
by: C. Lehmann, et al.
Published: (2015)

A Comparative Study On Perceptions And Practices Among Parents Of Thalassemic Children Attending Two Different Institutions
by: Bandyopadhyay Bhaswati, et al.
Published: (2003)

Iron Pathways and Iron Chelation Approaches in Viral, Microbial, and Fungal Infections
by: Ravneet Chhabra, et al.
Published: (2020)

Adverse Reactions Following Influenza Vaccination Among Health Care Personnel at Govt. Medical College, Miraj - A Longitudinal Study
by: Jayashree Dayanand Naik, et al.
Published: (2011)

Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program
by: Sruamsiri Rosarin, et al.
Published: (2013)

Comparative efficacy, safety, and cost of iron chelation monotherapy vs. combination therapy in pediatric beta-thalassemia major: a single-center retrospective study
by: Dewi Sharon Simorangkir, et al.
Published: (2022)

The Efficacy of Iron Chelators for Removing Iron from Specific Brain Regions and the Pituitary-Ironing out the Brain
by: Robert R. Crichton, et al.
Published: (2019)

Evaluating Health-Related Quality of Life (HRQoL) in Iraqi Adult and Pediatric Patients with Beta-Thalassemia Major Using Two Different Iron Chelation Therapies
by: Ali Jalal Shawkat, et al.
Published: (2019)

Chelation in Antibacterial Drugs: From Nitroxoline to Cefiderocol and Beyond
by: Davorka Repac Antić, et al.
Published: (2022)

REGIONAL SIDEROSIS: A NEW CHALLENGE FOR IRON CHELATION THERAPY
by: Zvi Ioav Cabantchik, et al.
Published: (2013)

Study of Iron Piperazine-Based Chelators as Potential Siderophore Mimetics
by: Pauline Loupias, et al.
Published: (2019)

New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases
by: Marco T. Nuñez, et al.
Published: (2018)

The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells
by: Michela Asperti, et al.
Published: (2019)

Profile of alanine aminotransferase and hepatic iron accumulation in thalassemic patients with or without anti-hepatitis C virus
by: Purnamawati S P, et al.
Published: (2016)

Coagulation defects in thalassemic patients
by: Mostafa M. Abosdera, et al.
Published: (2017)